Abstract
The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Current Diabetes Reviews
Title: Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Volume: 6 Issue: 1
Author(s): Olga Golubnitschaja
Affiliation:
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Abstract: The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Export Options
About this article
Cite this article as:
Golubnitschaja Olga, Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment, Current Diabetes Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339910790442637
DOI https://dx.doi.org/10.2174/157339910790442637 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Current Pharmaceutical Design COX-2 Inhibitors and Cardiovascular Events: Deja Vu Du Jour
Vascular Disease Prevention (Discontinued) Antioxidant Properties and Glucose Uptake Effect of Ethanol Extracts from Different Sweet Potato Leaves Prepared by Lyophilization and Oven- Drying at 40 °C
Current Nutrition & Food Science Editorial (Thematic Issue: “Pregnancy in Women with Metabolic Syndrome”)
Current Pharmaceutical Biotechnology Measuring Glycaemic Variation
Current Diabetes Reviews Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective
Current Neuropharmacology Diabetes Care: Risk Factors, Prediction, Prevention, and Individualized Treatment
Infectious Disorders - Drug Targets Modern Therapeutic Strategies for Autoimmune Diseases
Current Pharmaceutical Design Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
Current Drug Metabolism Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Current Pharmaceutical Design Nonalcoholic Fatty Liver Disease In Children: Recent Practice Guidelines, Where Do They Take Us?
Current Pediatric Reviews Substance P at the Neuro-Immune Crosstalk in the Modulation of Inflammation, Asthma and Antimicrobial Host Defense
Inflammation & Allergy - Drug Targets (Discontinued) History, Prevalence and Assessment of Limited Joint Mobility, from Stiff Hand Syndrome to Diabetic Foot Ulcer Prevention: A Narrative Review of the Literature
Current Diabetes Reviews Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery
Current Diabetes Reviews Is there a Role for Antioxidants in the Treatment of Stable Angina?
Current Pharmaceutical Design Hyperglycemic Hyperosmolar State Associated with Low-Dose Quetiapine Treatment in a Patient with Bipolar Disorder
Current Drug Safety Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations
Current Pharmaceutical Design Peptidomics Biomarker Discovery in Mouse Models of Obesity and Type 2 Diabetes
Combinatorial Chemistry & High Throughput Screening Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
Current Drug Targets